School of Medicine, Jiangsu University, Zhenjiang, China.
School of Medical Technology, Zhenjiang College, Zhenjiang, China.
Biosci Biotechnol Biochem. 2021 Mar 24;85(4):923-930. doi: 10.1093/bbb/zbaa110.
The overactivation of macrophages causes chronic inflammatory diseases. Short-chain fatty acids (SCFAs), potential drugs for clinical treatment, are modulators of macrophage inflammatory reaction. Therefore, the modulation of macrophage-mediated cell activity is expected to become a new therapeutic strategy for inflammatory diseases caused by Mycoplasma pneumoniae. In this study, 2 kinds of SCFAs (propionate and butyrate) were found to have anti-inflammatory effects in M. pneumoniae-stimulated THP-1 cells inflammatory. They inhibited the expressions of IL-4, IL-6, ROS, and NLRP3 inflammasome, while enhancing the expressions of IL-10 and IFN-γ. Our study revealed these 2 agents to repress transcriptional activities of NF-κB, which are important modulators of inflammation. Meanwhile, SCFAs can significantly enhance the autophagy induced by M. pneumoniae. Considering that SCFAs have few side effects, they might be the promising adjuvant therapy for the prevention and/or treatment of various inflammatory diseases.
巨噬细胞的过度激活会导致慢性炎症性疾病。短链脂肪酸(SCFAs)是一种有临床应用潜力的药物,可调节巨噬细胞炎症反应。因此,调节巨噬细胞介导的细胞活性有望成为一种治疗肺炎支原体引起的炎症性疾病的新策略。在这项研究中,发现 2 种 SCFAs(丙酸和丁酸)对肺炎支原体刺激的 THP-1 细胞炎症具有抗炎作用。它们抑制了 IL-4、IL-6、ROS 和 NLRP3 炎性体的表达,同时增强了 IL-10 和 IFN-γ的表达。我们的研究表明,这两种物质可以抑制 NF-κB 的转录活性,NF-κB 是炎症的重要调节因子。同时,SCFAs 可显著增强肺炎支原体诱导的自噬。鉴于 SCFAs 副作用较小,它们可能是预防和/或治疗各种炎症性疾病的有前途的辅助治疗药物。
Biosci Biotechnol Biochem. 2021-3-24
Front Immunol. 2025-4-22
Antioxidants (Basel). 2024-8-2
Clin Rev Allergy Immunol. 2024-6
Foods. 2022-9-15